These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26663090)

  • 1. Drug-induced photosensitivity to bicalutamide - case report and review of the literature.
    Lee K; Oda Y; Sakaguchi M; Yamamoto A; Nishigori C
    Photodermatol Photoimmunol Photomed; 2016 May; 32(3):161-4. PubMed ID: 26663090
    [No Abstract]   [Full Text] [Related]  

  • 2. Bicalutamide-induced gynaecomastia: do we have the answer?
    Di Lorenzo G; Autorino R
    Eur Urol; 2007 Jul; 52(1):5-8. PubMed ID: 17258386
    [No Abstract]   [Full Text] [Related]  

  • 3. Photosensitive drug eruption induced by bicalutamide within the UVB action spectrum.
    Sasada K; Sakabe J; Tamura A; Kasuya A; Shimauchi T; Ito T; Hirakawa S; Tokura Y
    Eur J Dermatol; 2012; 22(3):402-3. PubMed ID: 22503957
    [No Abstract]   [Full Text] [Related]  

  • 4. Bicalutamide-associated hallucinations in a metastatic prostate cancer patient: A case report.
    Turkkan G; Dogan C; Tek B
    J Oncol Pharm Pract; 2020 Jun; 26(4):1029-1031. PubMed ID: 31707924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of gynecomastia induced by bicalutamide].
    Haddad E
    Ann Urol (Paris); 2006 Dec; 40 Suppl 2():S49-52. PubMed ID: 17361921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients.
    Bedognetti D; Rubagotti A; Conti G; Francesca F; De Cobelli O; Canclini L; Gallucci M; Aragona F; Di Tonno P; Cortellini P; Martorana G; Lapini A; Boccardo F
    Eur Urol; 2010 Feb; 57(2):238-45. PubMed ID: 19481335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Images in clinical medicine. Gynecomastia induced by prostate-cancer treatment.
    Michalopoulos NV; Keshtgar MR
    N Engl J Med; 2012 Oct; 367(15):1449. PubMed ID: 23050528
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of change to flutamide for prostate cancer patient who developed breast pain during bicalutamide treatment (BIP-F study)].
    Kitamura Y; Okuno H; Sakura Y; Manabe Y; Masuda N; Ito H; Mishina M; Taoka R; Terai A; Sugimoto M; Kakehi Y
    Hinyokika Kiyo; 2014 Jan; 60(1):17-23. PubMed ID: 24594768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial comparing tamoxifen therapy vs. tamoxifen prophylaxis in bicalutamide-induced gynecomastia.
    Serretta V; Altieri V; Morgia G; Nicolosi F; De Grande G; Mazza R; Melloni D; Allegro R; Ferraù F; Gebbia V
    Clin Genitourin Cancer; 2012 Sep; 10(3):174-9. PubMed ID: 22502790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gynecomastia as a complication of hormonotherapy for prostate cancer: effect of prophylactic breast irradiation].
    Abdah-Bortnyak R; Bernstein Z; Ramon N; Zalman D; Shnaider J; Kuten A
    Harefuah; 2007 Feb; 146(2):126-8, 164-5. PubMed ID: 17352282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bicalutamide.
    Prescrire Int; 2007 Apr; 16(88):67. PubMed ID: 17458049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical onset of bicalutamide-induced liver injury.
    Yun GY; Kim SH; Kim SW; Joo JS; Kim JS; Lee ES; Lee BS; Kang SH; Moon HS; Sung JK; Lee HY; Kim KH
    World J Gastroenterol; 2016 Apr; 22(15):4062-5. PubMed ID: 27099451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial comment on: Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study.
    Van Poppel H
    Eur Urol; 2007 Jul; 52(1):115. PubMed ID: 17270341
    [No Abstract]   [Full Text] [Related]  

  • 14. Bicalutamide causes heart failure in an elderly patient with prostate cancer.
    Guirguis K
    Expert Opin Drug Saf; 2016; 15(3):297-302. PubMed ID: 26745594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of tamoxifen in reducing bicalutamide-induced gynaecomastia and breast pain.
    Nuttall MC; Harris JP; Dawkins GP
    BJU Int; 2007 Feb; 99(2):243-4. PubMed ID: 17313420
    [No Abstract]   [Full Text] [Related]  

  • 16. Is prophylactic breast radiotherapy necessary in all patients with prostate cancer and gynecomastia and/or breast pain?
    Ozen H; Akyol F; Toktas G; Eskicorapci S; Unluer E; Kuyumcuoglu U; Abay E; Cureklibatur I; Sengoz M; Yalcin V; Akpinar H; Zorlu F; Sengor F; Karaman I
    J Urol; 2010 Aug; 184(2):519-24. PubMed ID: 20620411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of Casodex (bicalutamide) in the treatment of disseminated prostatic cancer].
    Sivko AV; Prokhorov AV
    Urol Nefrol (Mosk); 1997; (3):49-52. PubMed ID: 9245060
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate cancer tissue is masked by bicalutamide: a case report.
    Ellinger J; Bastian PJ; Biermann K; Schmidt ME; Textor J; Bollmann D; Zhou H; Müller SC
    Eur J Med Res; 2007 May; 12(5):212-5. PubMed ID: 17513193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DRUG-INDUCED INTERSTITIAL LUNG DISEASE DURING COMBINED ANDROGEN BLOCKADE WITH BICALUTAMIDE AND LEUPRORELIN ACETATE FOR PROSTATE CANCER].
    Maeda K; Osafune T; Masuda Y; Takeda T; Kageyama S; Narita M; Kawauchi A
    Nihon Hinyokika Gakkai Zasshi; 2019; 110(1):36-40. PubMed ID: 31956217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years.
    Iversen P; McLeod DG; See WA; Morris T; Armstrong J; Wirth MP;
    BJU Int; 2010 Apr; 105(8):1074-81. PubMed ID: 22129214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.